Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
ConditionDiabetes Mellitus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).
Eligibility criteria
Qualifiers
Patients who are admitted to Advanced Care at Home (ACH) Program and supposed to remain in ACH for at least 72 hours.
Patients with previous diagnosis of DM type 1 or type 2.
Patients taking subcutaneous (SQ) insulin either via multidose injections or SQ insulin pump.
Capable of giving signed informed consent
Disqualifiers
Actively treated for diabetes ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS).
Participants taking acetaminophen more than 4g per day or more than 1gm every 6 hours.
Participants with altered mental status.
Participants diagnosed with dementia.
Trial design
Treatments tested in this trial
- Continuous Glucose Monitor Dexcom G6 PRO
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov